News – Page 580 – Endpoints News

AbbVie cuts away part of its partnership with Morphic on integrin research for fibrosis

4 years ago

Amicus and Perceptive call off SPAC merger for gene therapy spinout after recent setback

4 years ago

Merck drops out of a $125M KRAS alliance with Moderna, taking a step away from the Covid-19 star

4 years ago

When a citizen petition works: FDA's review of United Therapeutics' PAH drug extended to May

4 years ago

Precision immunology player bags $110M to fund its work on 'disease signature' tests

4 years ago

Pfizer drops case against ex-staffer accused of stealing trade secrets — including details about Covid-19 vaccine

4 years ago

Canada wants to clear the way for more decentralized clinical trials: Will the US follow suit?

4 years ago

DOJ scraps divisive China Initiative that swept up prominent scientists — but vows to keep guarding against ...

4 years ago

'F--- the feds': Martin Shkreli barred from running all public companies as judge decries remorseless behavior

4 years ago

Tillman Gerngross makes it official: He's out as CEO as troubled Adagio vows to soldier on

4 years ago

With a new startup, ARCH and Takeda wade into growing search for a Swiss Army knife RNA drug

4 years ago

Unidentified witnesses accuse Bristol Myers of scuttling timely FDA move on liso-cel to avoid $6.4B payout

4 years ago

Spectrum's penny stock takes another hit as CFO quietly plans exit

4 years ago

Moderna ties the knot with Thermo Fisher on a 15-year manufacturing alliance, gluing a global network

4 years ago

Building on CRISPR success, Intellia inks deal for new manufacturing facility in Waltham, MA

4 years ago

Akebia scrapes together $85M war chest to commercialize vada as PDUFA date looms

4 years ago

AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?

4 years ago

Pharma sustainability: Amgen debuts $750M ‘green bond,’ Merck initiates ESG goal review

4 years ago

FDA+ roundup: Assessor finds FDA's new biosimilar review model makes the process more predictable

4 years ago

Bayer oncology vet Robert LaCaze has his eyes on next steps — landing his first gig as CEO of Sadelain co-founded ...

4 years ago

With Spark safely tucked into Roche, its founding CEO is off to search for new adventures

4 years ago

Manufacturing reorg at Merck KGaA inspires a $500M+ investment in mRNA tech

4 years ago

Kiniksa inks licensing deal to take a Regeneron castoff into Asian markets

4 years ago

mRNA for all: WHO establishes biomanufacturing training hub in Korea

4 years ago

First page Previous page 577 578 579580581 582 583 Next page Last page